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To elucidate the pathogenesis of rheumatoid arthritis (RA), we used pro-
teomic analysis to determine the protein profile in a synovial cell line,
MH7A, established from patients with RA. Proteins were extracted from
MH7A cells that were or were not stimulated with tumor necrosis factor-a
(TNF-a), and then analyzed on a liquid chromatography/mass spectrome-
try system equipped with a unique long monolithic silica capillary. On the
basis of the results of this proteomic analysis, we identified 2650 proteins
from untreated MH7A cells and 2688 proteins from MH7A cells stimu-
lated with TNF-a. Next, we selected 269 differentially produced proteins
that were detected only under TNF-a stimulation, and classified these pro-
teins by performing gene ontology analysis by using DAVID as a func-
tional annotation tool. In TNF-a-stimulated MH7A cells, we observed
substantial production of plasminogen-activator inhibitor 2 and apoptosis-
regulating proteins such as BH3-interacting domain death agonist, auto-
phagy protein 5, apolipoprotein E, and caspase-3. These results indicate
that the upregulation of plasminogen-activator inhibitor 2 and apoptosis-
regulating proteins in synovial cells in response to TNF-a stimulation might
represent a predominant factor that contributes to the pathogenesis of RA.
Rheumatoid arthritis (RA) is characterized by a prolif-
eration of synovial cells that leads to joint destruction
[1]. The pathogenesis of RA comprises a preclinical
stage involving the generation of autoantibodies, an
initiation stage in which synovial inflammation
emerges, and a clinical stage dominated by synovial
inflammation and joint destruction [2]. In RA patho-
genesis, a central role is played by cytokines derived
from macrophages and fibroblast-like synoviocytes
(FLS), such as tumor necrosis factor-a (TNF-a) and
interleukin-6 (IL-6) [3]. RA FLS have been described
as transformed cells and they share morphologic fea-
tures with tumor cells, such as resistance to apoptosis,
potentially due to somatic mutations in p53 [4], and
RA FLS display and retain an invasive capacity
against articular cartilage [5]. Although FLS are the
major synovial producers of IL-6, a key pathogenic
cytokine [6,7], macrophages are likely the major source
of synovial TNF-a, a critical driver of the synovial
inflammation that occurs in RA [4,7]. However,
macrophages produce TNF-a only transiently [8] and
FLS are the major responders to TNF-a, which
Abbreviations
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suggest that TNF-a-stimulated FLS are crucial for
the pathogenesis of RA [9]. Therefore, we sought
to identify the functional protein profile in FLS
stimulated by TNF-a.
Proteome analysis is an indispensable technique for
comprehensively analyzing differences in protein pro-
duction. One of the critical purposes of clinical pro-
teome analysis is the identification of biomarkers for
disease diagnosis and therapeutic intervention: the
biomarkers are identified by analyzing the proteome
profiles of disease states and other physiologic states
[10]. Recent high-throughput and sensitive mass spec-
troscopy (MS) based on proteome-analysis technology
has provided a novel methodology for investigating
the physiology and pathophysiology of numerous
medicinal samples. In the case of protein separation
coupled with MS analysis, two-dimensional polyacry-
lamide gel electrophoresis (2D-PAGE) has been
widely used, but the low-throughput performance of
2D-PAGE could become a disadvantage in analyses
that require the examination of several samples. The
shotgun method is an alternative approach used in
proteome analysis that involves liquid chromatography
(LC) and tandem MS [11]. Previously, we constructed
a system that exhibits ultraperformance in chromato-
graphic separation achieved with a long monolithic
silica capillary column; this system has enabled, for
example, successful one-shot identification of 1658
proteins produced in Mesorhizobium loti in nodule or
free-living conditions [12]. Thus, we adapted this nano
LC-MS/MS proteome-analysis system for investigation
into the mechanism of RA onset.
In this study, we stimulated a transformed FLS cell
line, MH7A [13–16], with TNF-a and analyzed the
intracellular protein profile by using an LC-MS/MS
system equipped with a 500-cm-long monolithic silica
capillary column. We observed substantial production
of plasminogen-activator inhibitor (PAI) 2 and several
apoptosis-regulating proteins in TNF-a-stimulated
MH7A cells. Thus, TNF-a-stimulated upregulation of
PAI-2 and apoptosis-regulating proteins in synovial




The human MH7A synovial cell line (Riken, Saitama,
Japan), which originated from intra-articular soft tissue of
the knee joints of an RA patient, was established by trans-
fecting cells with SV40 T antigen [13–16]. MH7A cells were
cultured in Pure Coat 6-well plates (BD, Franklin Lakes,
NJ, USA) with RPMI 1640 medium (Sigma, St. Louis,
MO, USA) containing 10% heat-inactivated fetal bovine
serum (Whittaker, Walkersville, MD, USA) and
100 UmL1 penicillin and 100 lgmL1 streptomycin
(Invitrogen, Carlsbad, CA, USA). The culture plates were
incubated for 24 h at 37 °C in an atmosphere of 5% CO2
in air. Subsequently, the plates were incubated for another
24 h in the presence or absence of 100 ngmL1 TNF-a.
Protein preparation
Culture medium was aspirated from culture plates and the
cells were washed twice with ice-cold PBS, after which ice-
cold PBS was added to the wells and cells were removed
from the plates by using a cell-scraper. These collected cells
were transferred to conical tubes and total proteins were
extracted using a Qproteome Mammalian Protein Prep Kit
(Qiagen, Hilden, Germany).
Trypsin digestion
We mixed 1 mL of the protein supernatant with 135 lL of
200 mM triethylammonium bicarbonate (TEAB), 165 lL of
distilled water, and 15 lL of 200 mM tris-(2-carboxyethyl)
phosphine (Thermo Fisher Scientific, Waltham, MA,
USA). The mixture was incubated at 55 °C for 1 h, after
which 15 lL of 375 mM iodoacetamide was added to the
solution and incubated for 30 min. Next, the reactants were
mixed with 3 mL of ice-cold acetone and incubated at
20 °C for 2 h to precipitate proteins. Last, the precipi-
tated proteins were resuspended in 100 lL of TEAB and
mixed with 2 lL of 1 lglL1 sequencing-grade modified
trypsin (Promega, Madison, WI, USA) at 37 °C overnight.
LC-MS/MS analysis
Proteome analyses were performed using an LC-MS system
(LC, UltiMate 3000 RSLCnano System, and MS, LTQ
Velos Orbitrap mass spectrometer; Thermo Fisher Scien-
tific) that was equipped with a long monolithic silica capil-
lary column (500 cm long, 0.1 mm ID; Kyoto Monotech,
Kyoto, Japan). Tryptic digests (5 lL) were injected and
separated through reversed-phase chromatography at a
flow rate of 500 nLmin1; the gradient was produced by
changing the mixing ratio of these two eluents: A, 0.1%
(v/v) formic acid, and B, 80% (v/v) acetonitrile containing
0.1% (v/v) formic acid. The gradient was started with 5%
B, increased to 45% B for 600 min, further increased to
95% B to wash the column, and then returned to the initial
condition and held for re-equilibration. The separated ana-
lytes were detected on a mass spectrometer with a full scan
range of 350–1500 m/z. For data-dependent acquisition, the
method was set to automatically analyze the top-10 most
intense ions observed in the MS scan. An ESI voltage of
2.3 kV was applied directly to the LC buffer distal to the
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chromatography column by using a MicroTee. The temper-
ature of the ion transfer tube was set to 280 °C.
Data analysis
All samples were subjected to triplicate LC-MS/MS analysis,
and the combined spectrometry data were used for protein
identification. Proteins were identified by using MASCOT
(Matrix Science, London, UK) against the assembly 21 pro-
tein database at SwissProt (2002–2015 UniProt Consortium,
EMBL-EBI) that contains 20210 sequences, with a precursor
mass tolerance of 20 ppm, fragment tolerance of 0.8 Da,
and strict specificity allowing for up to one missed cleavage.
For trypsin digestion, carbamidomethylation of cysteine was
set as a fixed modification, and oxidation of methionine was
set as a dynamic modification. The data were then filtered at
a q-value ≤ 0.01 corresponding to 1% false-discovery rate
on a spectral level. Triplicate analyses were performed for
each sample of three biological replicates. The protein iden-
tification threshold was as follows; proteins identified using
more than one unique peptide and three peptides; if not,
proteins identified using a single unique peptide for each
biological replicate. For gene ontology (GO) analysis, the
DAVID annotation tool was used. A significant enrichment
score means that the number of identified proteins belonging
to their annotation term is significantly enriched comparing
to the number of genes belonging to that. For comparing
the protein amount of each gene, exponentially modified
protein abundance index (emPAI) [17] was calculated with
MACOT. An emPAI offers approximate, semiquantitative
value. It is developed by Ishihama et al. [17] and emPAI val-
ues were calculated from number of identified peptides per
protein and identifiable peptides per protein.
Results
Screening for differentially produced proteins
We conducted three independent experiments by using
cultured MH7A cells that were untreated or stimulated
with TNF-a. On the basis of the results of the pro-
teome analysis, we identified 2650 proteins from
untreated MH7A cells and 2688 proteins from TNF-a-
stimulated MH7A cells, and then selected 269 differen-
tially produced proteins that were detected under
TNF-a stimulation (Fig. 1).
GO analysis of differentially produced proteins
The proteins that were differentially produced follow-
ing stimulation with TNF-a were classified according
to GO analysis performed by using DAVID as the
A
B
Fig. 1. Summary of protein identification in MH7A cells. (A) Venn diagram of identified proteins; (B) gene ontology analysis of proteins
identified with/without TNF-a stimulation.
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functional annotation tool. The enrichment scores
obtained for protein localization, negative regulation
of apoptosis, regulation of apoptosis, protein localiza-
tion in mitochondria, apoptosis, heme metabolic pro-
cess, and T-cell activation were 4.28, 3.05, 2.37, 2.18,
1.87, 1.76, and 1.56, respectively (Fig. 1).
Plasminogen-activator inhibitor 2 and apoptosis-
regulating proteins
Among the differentially produced proteins analyzed,
we detected TNF-a signaling proteins such as nuclear
factor-kappa-B (NF-jB) and AP-1 complex subunit
r1A, and synovial cell growth proteins such as trans-
forming growth factor-b1 and IL-6 receptor-b. We
also observed substantial production of PAI-2 and
apoptosis-regulating proteins such as BH3-interacting
domain death agonist (BID), autophagy protein 5
(ATG5), apolipoprotein E (ApoE), and caspase-3 in
TNF-a-stimulated MH7A cells (Table 1).
Discussion
In TNF-a-stimulated MH7A cells, we detected NF-jB
and AP-1 complex subunit r1A. This suggested that
TNF-a-induced intracellular signaling (Fig. 2) was
Table 1. Exponentially modified protein abundance index (emPAI)
value of identified proteins. emPAI is defined as, emPAI = 10PAI1.







P62745 0.58 Rho-related GTP-binding protein RhoB
Q9Y5J9 0.36 Mitochondrial import inner membrane
translocase subunit Tim8 B
O60831 0.3 PRA1 family protein 2
Q9BRG1 0.29 Vacuolar protein-sorting-associated
protein 25
P62072 0.22 Mitochondrial import inner membrane
translocase subunit Tim10
Q9NQY0 0.2 Bridging integrator 3
P61966 0.18 AP-1 complex subunit sigma-1A
Q13637 0.18 Ras-related protein Rab-32
O00560 0.17 Syntenin-1
Negative regulation of apoptosis
P05120 1.21 Plasminogen activator inhibitor 2 (PAI-2)
O60936 0.24 Nucleolar protein 3
P37840 0.24 Alpha-synuclein
P16989 0.16 Y-box-binding protein 3
Q9UEE9 0.14 Craniofacial development protein 1
P42574 0.1 Caspase-3
Q9H1Y0 0.1 Autophagy protein 5 (ATG5)
P02649 0.09 Apolipoprotein E
Q86SJ2 0.06 Amphoterin-induced protein 2
P19838 0.05 Nuclear factor NF-kappa-B p105 subunit
Regulation of apoptosis
P05120 1.21 Plasminogen activator inhibitor 2 (PAI-2)
O60936 0.24 Nucleolar protein 3
P37840 0.24 Alpha-synuclein
P16989 0.16 Y-box-binding protein 3
P31483 0.16 Nucleolysin TIA-1 isoform p40
P55957 0.15 BH3-interacting domain death agonist (BID)
Q9UEE9 0.14 Craniofacial development protein 1
P42574 0.1 Caspase-3
Q6SZW1 0.1 Sterile alpha and TIR motif-containing
protein 1
Q9H1Y0 0.1 Autophagy protein 5 (ATG5)
Protein localization of mitochondrium
Q9Y5J9 0.36 Mitochondrial import inner membrane
translocase subunit Tim8 B
P62072 0.22 Mitochondrial import inner membrane
translocase subunit Tim10
P55957 0.15 BH3-interacting domain death agonist (BID)
P01137 0.07 Transforming growth factor beta-1
Q96BW9 0.06 Mitochondrial translocator assembly and
maintenance protein 41 homolog
P30536 0 Translocator protein
Apoptosis
P62745 0.58 Rho-related GTP-binding protein RhoB
O60936 0.24 Nucleolar protein 3







Q8IXM3 0.22 39S ribosomal protein L41, mitochondrial
P31483 0.16 Nucleolysin TIA-1 isoform p40
P55957 0.15 BH3-interacting domain death agonist (BID)
P42574 0.1 Caspase-3
Q9H1Y0 0.1 Autophagy protein 5 (ATG5)
Q9NXR7 0.08 BRCA1-A complex subunit BRE
O43464 0.07 Serine protease HTRA2, mitochondrial
Heme metabolic process
Q96EY8 0.16 Cob(I)yrinic acid a,c-diamide
adenosyltransferase, mitochondrial
P13716 0.12 Delta-aminolevulinic acid dehydratase
P13196 0.09 5-aminolevulinate synthase, nonspecific,
mitochondrial
Q9NQX3 0.04 Gephyrin
P30536 0 Translocator protein
T-cell activation
Q9BQ51 0.11 Programmed cell death 1 ligand 2
P42574 0.1 Caspase-3
P01137 0.07 Transforming growth factor beta-1
Q6QNY0 0.05 Biogenesis of lysosome-related organelles
complex 1 subunit 3
P40189 0.02 Interleukin-6 receptor subunit beta
P04626 0 Receptor tyrosine-protein kinase erbB-2
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operating in the MH7A cells used in this experiment
[18].
In MH7A cells stimulated with TNF-a, PAI-2 was
also produced. Abnormalities of the synovial lining
layer might represent an extremely early feature of
synovitis in RA. Even in an early clinical stage, the
surface of the synovial lining layer is frequently cov-
ered with fibrin deposits generated from the activation
of the fibrinolytic system by synovial fluid. The syn-
ovial lining layer is completely replaced by a fibrin
cap, and in highly inflamed tissues, this fibrin can
extend into the sublining layers.
Proteolytic digestion of the fibrin clot is mediated by
plasminogen activation. The plasminogen activation
system has been widely suggested to play a crucial
pathogenic role in destructive joint disease [19–21].
Busso et al. [22] reported that the concentrations of
urokinase-type plasminogen activator (u-PA), PAI-1,
PAI-2, and u-PA receptor were markedly higher in
RA patients than in osteoarthritis patients. The u-PA,
u-PA receptor, and PAI proteins produced in
increased amounts were distributed mainly in the syn-
ovial lining area of proliferative and invasively grow-
ing synovial tissue in RA patients [22]. Our detection
of substantial PAI-2 production in MH7A cells after
TNF-a stimulation potentially supports these previous
observations (Table 1).
We detected markedly increased production of
apoptosis-regulating proteins such as ApoE, ATG5,
and BID in TNF-a-stimulated MH7A cells (Table 1).
ApoE might play a role in RA. A recent study demon-
strated that ApoE-deficient mice were resistant to the
development of collagen-induced arthritis [23]. Syno-
vial fluid samples collected from the inflamed joints of
RA patients contain several citrullinated proteins.
Citrullinated ApoE is a newly identified antigen in RA
synovial fluid, and only a limited number of the pro-
tein’s citrullinated epitopes are targeted by the immune
system in RA [24]. Thus, the increased ApoE produc-
tion in TNF-a-stimulated MH7A cells observed here
suggests that the induction of citrullinated ApoE and
autoimmune reactions could be involved in RA devel-
opment (Fig. 2).
Autophagy is a highly conserved lysosome-mediated
catabolic process and a homeostatic process that
degrades unnecessary or dysfunctional cellular orga-
nelles and recycles nutrients. ATG5 is a critical protein
required for autophagy at the stage of autophago-
some-precursor synthesis. In addition to regulating
autophagosome formation, ATG5 might play an
important role in apoptosis [25–27]. Moreover, ATG5
regulates the production of inflammatory cytokines,
the functions of antigen-presenting cells, and the clear-
ance of apoptotic cells, which indicates that ATG5
might contribute to the pathogenesis of RA [28–31].
Our finding that ATG5 production was increased in
TNF-a-stimulated MH7A cells suggests that apoptosis
induction and immune-function regulation by this pro-
tein could underlie the development of RA (Fig. 2).
BID is a pro-apoptotic BH3-only Bcl-2 homolog
that is involved in “extrinsic” apoptosis: BID is acti-
vated by cleavage only in response to cell-surface
receptors that transmit apoptotic signals initiated by
the specific ligand granzyme B produced by cytotoxic
cells [32]. Peripheral blood neutrophils that were
dying spontaneously as a result of apoptosis (i.e.,
through “intrinsic” apoptosis) showed no BID cleav-
age despite efficient caspase-3 activation. By contrast,
Fig. 2. Intracellular signaling by TNF-a. An
up arrow means that molecules were
detected in this study.
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prominent BID cleavage was detected in neutrophils
that were exposed to granzyme B/perforin or in
neutrophils in which death receptor was activated
(with anti-Fas or TNF-a/cycloheximide). In RA
synovial fluid, BID cleavage was closely associated
with the cleavage of caspase-3 [33]. The increased
BID production in TNF-a-stimulated MH7A cells
observed in this study suggests that RA development
might involve BID activation-dependent induction of
apoptosis (Fig. 2).
Previously, TNF-a was demonstrated to induce pro-
longed activation of NF-jB signaling and transcription
of mRNAs encoding IL-6 and chemokines and chemo-
kine receptors such as CXCL8/IL-8 and CCL5/
RANTES [34]. A comparative proteomics study previ-
ously showed that proteins related to vasculature
development were upregulated in RA FLS as com-
pared with the corresponding levels in normal FLS
[35]. However, this study has demonstrated for the first
time that the plasminogen activation system is upregu-
lated in synovial cells after TNF-a stimulation
(Fig. 2).
In conclusion, we detected substantial production of
PAI-2 and several apoptosis-regulating proteins in
TNF-a-stimulated MH7A cells. Our results indicate
that these upregulated proteins might contribute to the
pathogenesis of RA.
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